191.14
前日終値:
$186.43
開ける:
$185.43
24時間の取引高:
1.71M
Relative Volume:
1.05
時価総額:
$31.90B
収益:
$16.63B
当期純損益:
$1.39B
株価収益率:
23.69
EPS:
8.0674
ネットキャッシュフロー:
$2.12B
1週間 パフォーマンス:
+13.93%
1か月 パフォーマンス:
+17.99%
6か月 パフォーマンス:
-15.77%
1年 パフォーマンス:
+20.85%
Iqvia Holdings Inc Stock (IQV) Company Profile
Compare IQV vs TMO, DHR, IDXX, A, NTRA
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
IQV
Iqvia Holdings Inc
|
191.14 | 31.12B | 16.63B | 1.39B | 2.12B | 8.0674 |
|
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
|
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
|
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-09 | アップグレード | TD Cowen | Hold → Buy |
| 2026-03-06 | アップグレード | Barclays | Equal Weight → Overweight |
| 2026-03-03 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-12-02 | 再開されました | Morgan Stanley | Overweight |
| 2025-11-13 | 開始されました | BMO Capital Markets | Outperform |
| 2025-11-03 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-10-29 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2025-10-09 | アップグレード | HSBC Securities | Hold → Buy |
| 2025-09-09 | アップグレード | Jefferies | Hold → Buy |
| 2025-04-25 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-04-10 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2025-02-03 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-12-20 | 開始されました | Stephens | Overweight |
| 2024-10-14 | 開始されました | Redburn Atlantic | Buy |
| 2024-09-04 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-07-24 | ダウングレード | Jefferies | Buy → Hold |
| 2024-06-06 | 開始されました | Goldman | Buy |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-02-15 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-02-13 | 開始されました | BTIG Research | Buy |
| 2023-11-02 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | 開始されました | HSBC Securities | Buy |
| 2023-03-17 | 開始されました | Truist | Buy |
| 2022-12-06 | 開始されました | Cowen | Outperform |
| 2022-11-17 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-07-15 | 開始されました | SVB Leerink | Outperform |
| 2022-05-24 | 開始されました | Guggenheim | Buy |
| 2022-04-29 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-04-16 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2020-07-07 | 開始されました | Stephens | Equal-Weight |
| 2020-03-02 | 開始されました | Deutsche Bank | Buy |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-12-13 | アップグレード | CFRA | Sell → Hold |
| 2019-11-14 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | アップグレード | Mizuho | Neutral → Buy |
| 2019-05-28 | 開始されました | SVB Leerink | Outperform |
| 2019-01-18 | アップグレード | Jefferies | Hold → Buy |
| 2018-10-09 | 開始されました | UBS | Buy |
| 2018-10-02 | 繰り返されました | Robert W. Baird | Outperform |
| 2018-07-25 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | 繰り返されました | Stifel | Buy |
| 2018-07-03 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | アップグレード | Goldman | Neutral → Buy |
| 2018-03-07 | アップグレード | SunTrust | Hold → Buy |
| 2018-01-19 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Iqvia Holdings Inc (IQV) 最新ニュース
IQVIA Holdings consensus stays constructive, shares trade near record territory - Ad-hoc-news.de
IQV Forecast — Price Target — Prediction for 2027 - TradingView
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MSN
QTS Forecast — Price Target — Prediction for 2027 - TradingView
IQVIA Holdings chart picture stays robust, shares above key 200-day mark - Ad-hoc-news.de
Are Wall Street analysts predicting IQVIA Holdings stock will climb or sink? - MSN
IQVIA Holdings Inc (IQV) Shares Surge 8.4% -- What GF Score of 8 - GuruFocus
IQVIA Holdings Jumps 7.4% Amid Sector-Wide Rally - AlphaStreet
Barclays Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $210 - Moomoo
IQVIA - Forbes
Charles River upgraded, IQVIA downgraded as Morgan Stanley revisits CRO coverage - MSN
Pharmacovigilance Automation Market Size to Reach USD 5.25 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
OCE from IQVIA Holdings Inc.cloud CRM that speaks pharma’s language - Ad-hoc-news.de
Does Slower Growth at IQVIA Holdings (IQV) Challenge Its Core Data‑Driven Pharma Enablement Story? - Yahoo Finance
IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
IQVIA Holdings trades in a tight range, technicals flag cautious signal for the shares - AD HOC NEWS
IQVIA Holdings Inc (IQV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IQVIA Holdings analyst views shift, shares trade below recent targets - Ad-hoc-news.de
IQVIA Holdings, Inc. (IQV): Investor Outlook On A 34% Potential Upside - DirectorsTalk Interviews
IQVIA Holdings Inc (IQV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IQVIA HoldingsAnalyst consensus and long-term drivers - AD HOC NEWS
Why IQVIA’s Orchestrated Customer Engagement quietly shapes pharma sales - AD HOC NEWS
IQVIA Holdings StockMorgan Stanley cuts rating and trims target - Ad-hoc-news.de
Morgan Stanley Maintains IQVIA Holdings(IQV.US) With Hold Rating, Raises Target Price to $225 - Moomoo
IQV News | IQVIA HOLDINGS INC (NYSE:IQV) - ChartMill
IQVIA Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
IQVIA Holdings Inc (IQV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IQVIA Holdings Inc (IQV) Valuation: PE, PB & Fair Value Analysis - TradingKey
IQVIA Holdings Inc (IQV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IQVIA Holdings Inc (IQV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IQVIA Holdings Inc (IQV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Saratoga Health & Biotechnology Fund's IQVIA Holdings Inc(IQV) Holding History - GuruFocus
IQVIA Holdings Inc (IQV) Institutional Confidence - TradingKey
IQVIA Holdings Inc (IQV) Stock Price, Trades & News - GuruFocus
Is IQVIA Holdings Inc (IQV) a Bargain After 4.7% Drop? GF Value Says Undervalued - GuruFocus
IQVIA Holdings Inc (IQV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IQVIA Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IQVIA Holdings, Inc. Stock 12‑Month Price Target Cut to $223.28, Implies 25% Upside - TradingView
IQV Downgraded by Morgan Stanley -- Price Target Lowered to $200 - GuruFocus
Why is IQVIA Holdings stock sliding today? By Investing.com - Investing.com Nigeria
Morgan Stanley Downgrades IQVIA Holdings to Equalweight From Overweight, Adjusts Price Target to $200 From $225 - marketscreener.com
Morgan Stanley downgrades IQVIA stock rating on margin concerns - Investing.com UK
Morgan Stanley Downgrades IQVIA Holdings(IQV.US) to Hold Rating, Cuts Target Price to $200 - Moomoo
(IQV) Risk Channels and Responsive Allocation - Stock Traders Daily
IQVIA Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Global Healthcare Infrastructure Strengthens IQV Amid Weak Liquidity - The Globe and Mail
IQVIA Holdings Stock (US46266C1053): Analyst Views and Valuation Under the Microscope - AD HOC NEWS
Here's why IQVIA Holdings (IQV) is a strong momentum stock - MSN
Wiley and IQVIA Release Cross-Sector Report on AI’s Promise and Pressure Points Across Healthcare Value Chain - Financial Times
IQVIA Holdings, Inc. (IQV) Stock Analysis: Exploring a Potential 25% Upside in Healthcare Innovation - DirectorsTalk Interviews
IQV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Iqvia Holdings Inc (IQV) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):